Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 207

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Reconstructing the early global dynamics of under-ascertained COVID-19 cases and infections

Open access
Russell, Timothy W., Golding, Nick, Hellewell, Joel, Abbott, Sam, Wright, Lawrence, Pearson, Carl A. B., van Zandvoort, Kevin, Jarvis, Christopher I., Gibbs, Hamish, Liu, Yang, Eggo, Rosalind M., Edmunds, W. John, Kucharski, Adam J., CMMID COVID-19 working group, Deol, Arminder K., Villabona-Arenas, C. Julian, Jombart, Thibaut, O’Reilly, Kathleen, Munday, James D., Meakin, Sophie R., Lowe, Rachel, Gimma, Amy, Endo, Akira, Nightingale, Emily S., Medley, Graham, Foss, Anna M., Knight, Gwenan M., Prem, Kiesha, Hué, Stéphane, Diamond, Charlie, Rudge, James W., Atkins, Katherine E., Auzenbergs, Megan, Flasche, Stefan, Houben, Rein M. G. J., Quilty, Billy J., Klepac, Petra, Quaife, Matthew, Funk, Sebastian, Leclerc, Quentin J., Emery, Jon C., Jit, Mark, Simons, David, Bosse, Nikos I., Procter, Simon R., Sun, Fiona Yueqian, Clifford, Samuel, Sherratt, Katharine, Rosello, Alicia, Davies, Nicholas G., Brady, Oliver, Tully, Damien C., Gore-Langton, Georgia R.·2020·BMC Medicine

Abstract

Background: Asymptomatic or subclinical SARS-CoV-2 infections are often unreported, which means that confirmed case counts may not accurately reflect underlying epidemic dynamics. Understanding the level of ascertainment (the ratio of confirmed symptomatic cases to the true number of symptomatic individuals) and undetected epidemic progression is crucial to informing COVID-19 response planning, including the introduction and relaxation of control measures. Estimating case ascertainment over time allows for accurate estimates of specific outcomes such as seroprevalence, which is essential for planning control measures. Methods: Using reported data on COVID-19 cases and fatalities globally, we estimated the proportion of symptomatic cases (i.e. any person with any of fever ≥ 37.5 °C, cough, shortness of breath, sudden onset of anosmia, ageusia or dysgeusia illness) that were reported in 210 countries and territories, given those countries had experienced more than ten deaths. We used published estimates of the baseline case fatality ratio (CFR), which was adjusted for delays and under-ascertainment, then calculated the ratio of this baseline CFR to an estimated local delay-adjusted CFR to estimate the level of under-ascertainment in a particular location. We then fit a Bayesian Gaussian process model to estimate the temporal pattern of under-ascertainment. Results: Based on reported cases and deaths, we estimated that, during March 2020, the median percentage of symptomatic cases detected across the 84 countries which experienced more than ten deaths ranged from 2.4% (Bangladesh) to 100% (Chile). Across the ten countries with the highest number of total confirmed cases as of 6 July 2020, we estimated that the peak number of symptomatic cases ranged from 1.4 times (Chile) to 18 times (France) larger than reported. Comparing our model with national and regional seroprevalence data where available, we find that our estimates are consistent with observed values. Finally, we estimated seroprevalence for each country. As of 7 June, our seroprevalence estimates range from 0% (many countries) to 13% (95% CrI 5.6–24%) (Belgium). Conclusions: We found substantial under-ascertainment of symptomatic cases, particularly at the peak of the first wave of the SARS-CoV-2 pandemic, in many countries. Reported case counts will therefore likely underestimate the rate of outbreak growth initially and underestimate the decline in the later stages of an epidemic. Although there was considerable under-reporting in many locations, our estimates were consistent with emerging serological data, suggesting that the proportion of each country’s population infected with SARS-CoV-2 worldwide is generally low.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12916-020-01790-9

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 207

Metadata

Authors
Russell, T. W., Golding, N., Hellewell, J., Abbott, S., Wright, L., Pearson, C. A. B., van Zandvoort, K., Jarvis, C. I., Gibbs, H., Liu, Y., Eggo, R. M., Edmunds, W. J., Kucharski, A. J., CMMID COVID-19 working group, Deol, A. K., Villabona-Arenas, C. J., Jombart, T., O’Reilly, K., Munday, J. D., Meakin, S. R., Lowe, R., Gimma, A., Endo, A., Nightingale, E. S., Medley, G., Foss, A. M., Knight, G. M., Prem, K., Hué, S., Diamond, C., Rudge, J. W., Atkins, K. E., Auzenbergs, M., Flasche, S., Houben, R. M. G. J., Quilty, B. J., Klepac, P., Quaife, M., Funk, S., Leclerc, Q. J., Emery, J. C., Jit, M., Simons, D., Bosse, N. I., Procter, S. R., Sun, F. Y., Clifford, S., Sherratt, K., Rosello, A., Davies, N. G., Brady, O., Tully, D. C., & Gore-Langton, G. R.
Venue
BMC Medicine
Published
2020-10-22
Volume
18
Issue
1
Pages
332-332
ISSN
1741-7015 (ISSN-L)
OpenAlex
W3093931808
Cited by
207
References
2
FWCI
6.34
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Reconstructing the early global dynamics of under-ascertained COVID-19 cases and infections. https://app.cochat.ai/papers/10.1186/s12916-020-01790-9
The paper
Russell, T. W., Golding, N., Hellewell, J., Abbott, S., Wright, L., Pearson, C. A. B., van Zandvoort, K., Jarvis, C. I., Gibbs, H., Liu, Y., Eggo, R. M., Edmunds, W. J., Kucharski, A. J., CMMID COVID-19 working group, Deol, A. K., Villabona-Arenas, C. J., Jombart, T., O’Reilly, K., Munday, J. D., . . . Gore-Langton, G. R. (2020). Reconstructing the early global dynamics of under-ascertained COVID-19 cases and infections. BMC Medicine. https://doi.org/10.1186/s12916-020-01790-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.